10x Genomics: Q4 Earnings Insights

10x Genomics TXG reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

10x Genomics beat estimated earnings by 33.33%, reporting an EPS of $-0.24 versus an estimate of $-0.36.

Revenue was up $27.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 8.73% increase in the share price the next day.

Here's a look at 10x Genomics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.46 -0.39 -0.37 -0.31
EPS Actual -0.44 -0.53 -0.44 -0.15
Revenue Estimate 151.26M 138.97M 128.82M 148.69M
Revenue Actual 153.64M 146.82M 134.28M 156.23M

To track all earnings releases for 10x Genomics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

TXG Logo
TXG10x Genomics Inc
$9.054.87%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
7.12
Growth
14.85
Quality
-
Value
71.44
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...